• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

神经干细胞和大麻素成为癫痫治疗的潜在新靶点。

Neural Stem Cells and Cannabinoids in the Spotlight as Potential Therapy for Epilepsy.

机构信息

Instituto de Farmacologia e Neurociências, Faculdade de Medicina, Universidade de Lisboa, 1649-028 Lisboa, Portugal.

Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, 1649-028 Lisboa, Portugal.

出版信息

Int J Mol Sci. 2020 Oct 3;21(19):7309. doi: 10.3390/ijms21197309.

DOI:10.3390/ijms21197309
PMID:33022963
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7582633/
Abstract

Epilepsy is one of the most common brain diseases worldwide, having a huge burden in society. The main hallmark of epilepsy is the occurrence of spontaneous recurrent seizures, having a tremendous impact on the lives of the patients and of their relatives. Currently, the therapeutic strategies are mostly based on the use of antiepileptic drugs, and because several types of epilepsies are of unknown origin, a high percentage of patients are resistant to the available pharmacotherapy, continuing to experience seizures overtime. Therefore, the search for new drugs and therapeutic targets is highly important. One key aspect to be targeted is the aberrant adult hippocampal neurogenesis (AHN) derived from Neural Stem Cells (NSCs). Indeed, targeting seizure-induced AHN may reduce recurrent seizures and shed some light on the mechanisms of disease. The endocannabinoid system is a known modulator of AHN, and due to the known endogenous antiepileptic properties, it is an interesting candidate for the generation of new antiepileptic drugs. However, further studies and clinical trials are required to investigate the putative mechanisms by which cannabinoids can be used to treat epilepsy. In this manuscript, we will review how cannabinoid-induced modulation of NSCs may promote neural plasticity and whether these drugs can be used as putative antiepileptic treatment.

摘要

癫痫是全球最常见的脑部疾病之一,给社会带来了巨大的负担。癫痫的主要特征是自发性反复发作,这对患者及其亲属的生活产生了巨大影响。目前,治疗策略主要基于抗癫痫药物的使用,但由于多种类型的癫痫病因不明,相当一部分患者对现有药物治疗产生耐药性,随着时间的推移仍会出现癫痫发作。因此,寻找新的药物和治疗靶点非常重要。一个需要关注的关键方面是源自神经干细胞的异常成年海马神经发生(AHN)。事实上,针对癫痫发作引起的 AHN 可能会减少反复发作,并为疾病机制提供一些启示。内源性大麻素系统是 AHN 的已知调节剂,由于其具有已知的内源性抗癫痫特性,它是生成新型抗癫痫药物的一个有趣候选者。然而,需要进一步的研究和临床试验来探究大麻素治疗癫痫的潜在机制。在本文中,我们将综述大麻素诱导的神经干细胞调节如何促进神经可塑性,以及这些药物是否可用于潜在的抗癫痫治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3d9/7582633/229df98b982c/ijms-21-07309-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3d9/7582633/ce207115537c/ijms-21-07309-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3d9/7582633/40e7e485c2f5/ijms-21-07309-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3d9/7582633/6152b984db3a/ijms-21-07309-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3d9/7582633/b47a266f897f/ijms-21-07309-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3d9/7582633/229df98b982c/ijms-21-07309-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3d9/7582633/ce207115537c/ijms-21-07309-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3d9/7582633/40e7e485c2f5/ijms-21-07309-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3d9/7582633/6152b984db3a/ijms-21-07309-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3d9/7582633/b47a266f897f/ijms-21-07309-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3d9/7582633/229df98b982c/ijms-21-07309-g005.jpg

相似文献

1
Neural Stem Cells and Cannabinoids in the Spotlight as Potential Therapy for Epilepsy.神经干细胞和大麻素成为癫痫治疗的潜在新靶点。
Int J Mol Sci. 2020 Oct 3;21(19):7309. doi: 10.3390/ijms21197309.
2
Therapeutic effects of cannabinoids in animal models of seizures, epilepsy, epileptogenesis, and epilepsy-related neuroprotection.大麻素在癫痫发作、癫痫、癫痫发生及癫痫相关神经保护动物模型中的治疗作用。
Epilepsy Behav. 2017 May;70(Pt B):319-327. doi: 10.1016/j.yebeh.2016.11.006. Epub 2017 Feb 9.
3
Cannabinoids: is there a potential treatment role in epilepsy?大麻素:在癫痫治疗中是否具有潜在作用?
Expert Opin Pharmacother. 2015;16(13):1911-4. doi: 10.1517/14656566.2015.1074181. Epub 2015 Aug 3.
4
Cannabinoids and Epilepsy.大麻素与癫痫
Neurotherapeutics. 2015 Oct;12(4):747-68. doi: 10.1007/s13311-015-0375-5.
5
Cannabinoid regulation of neurons in the dentate gyrus during epileptogenesis: Role of CB1R-associated proteins and downstream pathways.大麻素在癫痫发生过程中对齿状回神经元的调节:CB1R 相关蛋白和下游途径的作用。
Epilepsia. 2023 Jun;64(6):1432-1443. doi: 10.1111/epi.17569. Epub 2023 Mar 20.
6
Effects of lamotrigine and topiramate on hippocampal neurogenesis in experimental temporal-lobe epilepsy.拉莫三嗪和托吡酯对实验性颞叶癫痫海马神经发生的影响。
Brain Res. 2010 Feb 8;1313:270-82. doi: 10.1016/j.brainres.2009.12.024. Epub 2009 Dec 16.
7
The Interplay between the Endocannabinoid System, Epilepsy and Cannabinoids.内源性大麻素系统、癫痫与大麻素之间的相互作用。
Int J Mol Sci. 2019 Dec 2;20(23):6079. doi: 10.3390/ijms20236079.
8
Cannabinoid Actions on Neural Stem Cells: Implications for Pathophysiology.大麻素对神经干细胞的作用:对发病机制的影响。
Molecules. 2019 Apr 5;24(7):1350. doi: 10.3390/molecules24071350.
9
Innovative treatments for epilepsy: Venom peptides, cannabinoids, and neurostimulation.癫痫的创新治疗方法:毒液肽、大麻素和神经刺激。
J Neurosci Res. 2022 Nov;100(11):1969-1986. doi: 10.1002/jnr.25114. Epub 2022 Aug 7.
10
The potential role of cannabinoids in epilepsy treatment.大麻素在癫痫治疗中的潜在作用。
Expert Rev Neurother. 2017 Nov;17(11):1069-1079. doi: 10.1080/14737175.2017.1373019. Epub 2017 Sep 4.

引用本文的文献

1
The Pharmacology of Cannabinoids in Chronic Pain.大麻素在慢性疼痛中的药理学
Med Cannabis Cannabinoids. 2025 Feb 5;8(1):31-46. doi: 10.1159/000543813. eCollection 2025 Jan-Dec.
2
Stem Cells: Recent Developments Redefining Epilepsy Therapy.干细胞:重新定义癫痫治疗的最新进展。
Cell Transplant. 2023 Jan-Dec;32:9636897231158967. doi: 10.1177/09636897231158967.

本文引用的文献

1
Comparison of the Neurotoxic and Seizure-Inducing Effects of Synthetic and Endogenous Cannabinoids with Δ-Tetrahydrocannabinol.合成大麻素和内源性大麻素与Δ-四氢大麻酚的神经毒性和致癫痫作用比较
Cannabis Cannabinoid Res. 2020 Feb 27;5(1):32-41. doi: 10.1089/can.2019.0003. eCollection 2020 Mar 1.
2
Long-term outcomes in temporal lobe epilepsy with glutamate decarboxylase antibodies.谷氨酸脱羧酶抗体相关颞叶癫痫的长期预后。
J Neurol. 2020 Jul;267(7):2083-2089. doi: 10.1007/s00415-020-09807-2. Epub 2020 Mar 28.
3
Mechanisms of action of currently used antiseizure drugs.
目前使用的抗癫痫药物的作用机制。
Neuropharmacology. 2020 May 15;168:107966. doi: 10.1016/j.neuropharm.2020.107966. Epub 2020 Jan 14.
4
The 'entourage effect' or 'hodge-podge hashish': the questionable rebranding, marketing, and expectations of cannabis polypharmacy.“伴随效应”或“大杂烩大麻”:对大麻多药治疗的重新包装、营销和预期的质疑。
Expert Rev Clin Pharmacol. 2020 Aug;13(8):835-845. doi: 10.1080/17512433.2020.1721281. Epub 2020 Mar 2.
5
Possible therapeutic applications of cannabis in the neuropsychopharmacology field.大麻在神经精神药理学领域的可能治疗应用。
Eur Neuropsychopharmacol. 2020 Jul;36:217-234. doi: 10.1016/j.euroneuro.2020.01.013. Epub 2020 Feb 10.
6
The endocannabinoid receptors CB1 and CB2 affect the regenerative potential of adipose tissue MSCs.内源性大麻素受体 CB1 和 CB2 影响脂肪组织间充质干细胞的再生潜能。
Exp Cell Res. 2020 Apr 1;389(1):111881. doi: 10.1016/j.yexcr.2020.111881. Epub 2020 Jan 29.
7
Endocannabinoid system and adult neurogenesis: a focused review.内源性大麻素系统与成年神经发生:重点综述。
Curr Opin Pharmacol. 2020 Feb;50:25-32. doi: 10.1016/j.coph.2019.11.002. Epub 2019 Dec 18.
8
Missing Pieces to the Endocannabinoid Puzzle.内源性大麻素系统谜题的缺失环节。
Trends Mol Med. 2020 Mar;26(3):263-272. doi: 10.1016/j.molmed.2019.11.002. Epub 2019 Dec 7.
9
Life and death in the hippocampus: What's bad?海马体中的生死:什么是不好的?
Epilepsy Behav. 2021 Aug;121(Pt B):106595. doi: 10.1016/j.yebeh.2019.106595. Epub 2019 Nov 20.
10
Reduced cannabinoid 2 receptor activity increases susceptibility to induced seizures in mice.大麻素 2 型受体活性降低可增加小鼠癫痫发作的易感性。
Epilepsia. 2019 Dec;60(12):2359-2369. doi: 10.1111/epi.16388. Epub 2019 Nov 22.